Year archive

NYRADA INC. — 2022 filings

All 40 regulatory filings released by NYRADA INC. (NYR) in 2022, sourced directly from the official regulator.

40 Filings

2022 Period

2022 filings (40)

Filing	Released	Lang
Nyrada AGM 2022 Chairmans Address 4 pages 367.1KB Regulatory Filings	2022-11-20	English
AGM Presentation by James Bonnar CEO 26 pages 1.5MB Regulatory Filings	2022-11-20	English
Results of Meeting 4 pages 257.3KB Regulatory Filings	2022-11-20	English
Nyrada Receives A$1.2M R&D Tax Incentive Rebate 2 pages 219.4KB Regulatory Filings	2022-11-17	English
CEO Remuneration Update 2 pages 198.1KB Regulatory Filings	2022-10-26	English
Quarterly Activities Report and Appendix 4C 10 pages 489.8KB Regulatory Filings	2022-10-25	English
2022 AGM Notice of Meeting and Proxy 30 pages 660.1KB Regulatory Filings	2022-10-17	English
2022 AGM Letter to Shareholders and Proxy 10 pages 644.6KB Regulatory Filings	2022-10-17	English
Efficacy Study Published in Journal of Lipid Research 2 pages 231.8KB Regulatory Filings	2022-10-09	English
Presentation to ShareCafe Hidden Gems Webinar 18 pages 1.2MB Regulatory Filings	2022-09-28	English
Presentation to E&P Small Caps Health Care Conference 27 pages 1.9MB Regulatory Filings	2022-09-04	English
Appendix 4G and Corporate Governance Statement 25 pages 2.8MB Regulatory Filings	2022-08-28	English
Preliminary Final Report 2 pages 216.3KB Regulatory Filings	2022-08-28	English
Annual Report to June 30 2022 64 pages 2.7MB Regulatory Filings	2022-08-28	English
Nyrada Reports Full Year FY2022 Results 5 pages 334.4KB Regulatory Filings	2022-08-28	English
Final Director's Interest Notice - PM 2 pages 5.3KB Regulatory Filings	2022-08-01	English
Initial Director's Interest Notice - GM 2 pages 144.2KB Regulatory Filings	2022-08-01	English
Nyrada Board Changes 2 pages 206.5KB Regulatory Filings	2022-08-01	English
Quarterly Activities Report and Appendix 4C 11 pages 446.9KB Regulatory Filings	2022-07-25	English
Nyrada PCSK9 Inhibitor Tested in Model of Atherosclerosis 2 pages 206.1KB Regulatory Filings	2022-07-19	English
Cholesterol-Lowering Program Update 2 pages 216.2KB Regulatory Filings	2022-06-28	English
Corporate Presentation 30 pages 1.9MB Regulatory Filings	2022-06-06	English
Brain Injury Program Target Unveiled and Phase I Update 6 pages 308.7KB Regulatory Filings	2022-06-05	English
European Patent to be Granted for Cholesterol-Lowering Drug 2 pages 224.5KB Regulatory Filings	2022-05-16	English
Nyrada Quarterly Activities Report & Appendix 4C 10 pages 434.3KB Regulatory Filings	2022-04-18	English
Investor Roadshow Presentation 22 pages 1.8MB Regulatory Filings	2022-03-29	English
New Drug Offers Potential Oral Treatment for Concussion 4 pages 302.0KB Regulatory Filings	2022-03-28	English
Presentation to Meet the CEO Life Sciences Edition 19 pages 1.8MB Regulatory Filings	2022-03-01	English
Appendix 4D and Half Year Report to 31 December 2021 21 pages 588.5KB Regulatory Filings	2022-02-24	English
Nyrada Half Year Results FY2022 4 pages 284.8KB Regulatory Filings	2022-02-24	English
Nyrada Quarterly Activities Report & Appendix 4C 11 pages 516.6KB Regulatory Filings	2022-01-20	English
Change of Director's Interest Notice - PM 3 pages 8.2KB Regulatory Filings	2022-01-16	English
Change of Director's Interest Notice - CC 3 pages 8.1KB Regulatory Filings	2022-01-16	English
Change of Director's Interest Notice - JM 2 pages 6.9KB Regulatory Filings	2022-01-16	English
Change of Director's Interest Notice - RW 3 pages 8.0KB Regulatory Filings	2022-01-16	English
Change of Director's Interest Notice - MF 3 pages 8.1KB Regulatory Filings	2022-01-16	English
Change of Director's Interest Notice - ID 3 pages 7.8KB Regulatory Filings	2022-01-16	English
Application for quotation of securities - NYR 6 pages 27.2KB Regulatory Filings	2022-01-16	English
Nyrada Receives A$1.3M R&D Tax Incentive Rebate 2 pages 220.0KB Regulatory Filings	2022-01-11	English
Brain Injury Program Update and Pathway to Phase I 4 pages 246.0KB Regulatory Filings	2022-01-03	English